Medicare Enrolled

Dr. Afshin Forouzannia, MD

Optician · Orlando, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2501 N ORANGE AVE STE 182, Orlando, FL 32804
4073035857
In practice since 2005 (20 years)
NPI: 1073597233 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Forouzannia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Forouzannia? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Forouzannia

Dr. Afshin Forouzannia is an optician specialist in Orlando, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Forouzannia performed 1,414 Medicare services across 663 unique beneficiaries.

Between the years covered by Open Payments, Dr. Forouzannia received a total of $3,309 from 32 pharmaceutical and/or device companies across 72 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Forouzannia is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 49% volume in FL $3,309 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 123173 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
1,414
Medicare services
Top 49% in FL for optician
663
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~71 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy 339 $15 $62
Design and construction of complex radiation treatment device 214 $48 $181
Calculation of radiation therapy dose 205 $26 $100
Radiation treatment management, 5 treatment sessions 183 $151 $577
Complex radiation therapy planning 63 $133 $511
Office visit, established patient (20-29 min) 55 $45 $200
New patient office visit, complex (60-74 min) 53 $144 $548
Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved 46 $65 $248
Office visit, established patient, complex (40-54 min) 41 $114 $431
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area 31 $30 $115
3d radiation therapy planning 30 $179 $675
Design and construction of radiation treatment device for high precision radiation therapy 24 $179 $675
CT guidance for radiation therapy 23 $32 $135
Initial hospital admission, high complexity 23 $135 $525
High precision radiation therapy planning 22 $334 $1,257
Office visit, established patient (30-39 min) 19 $62 $295
Special radiation treatment 16 $85 $322
New patient office visit (45-59 min) 16 $107 $404
Complex radiation therapy planning for delivery of external radiation 11 $121 $457
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,309
Total received (2020-2024)
Avg $662/year across 5 years
Top 29% in FL for optician
32
Companies
72
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,309 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$808
2023
$1,793
2022
$399
2021
$248
2020
$61

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Siemens Medical Solutions USA, Inc.
$1,114
Mevion_Medical_Systems_Inc
$293
Myriad Genetic Laboratories, Inc.
$267
Elekta, Inc.
$197
Boston Scientific Corporation
$148
AstraZeneca Pharmaceuticals LP
$125
VIEWRAY TECHNOLOGIES INC
$113
Novartis Pharmaceuticals Corporation
$108
Bayer Healthcare Pharmaceuticals Inc.
$98
Lilly USA, LLC
$93
Monteris Medical Corporation
$74
Daiichi Sankyo Inc.
$68
PFIZER INC.
$59
Blue Earth Diagnostics Limited
$47
Novocure Inc.
$42
Dendreon Pharmaceuticals LLC
$38
Tactile Systems Technology Inc
$36
Regeneron Healthcare Solutions, Inc.
$35
Merck Sharp & Dohme LLC
$34
Janssen Biotech, Inc.
$33
Napo Pharmaceuticals Inc
$32
GE HEALTHCARE
$28
Tolmar, Inc.
$28
Sumitomo Pharma America, Inc.
$27
Seagen Inc.
$27
Bayer HealthCare Pharmaceuticals Inc.
$25
Pharmacosmos Therapeutics Inc.
$24
EMD Serono, Inc.
$22
Myovant Sciences Inc.
$20
Kyowa Kirin, Inc.
$18
Takeda Pharmaceuticals U.S.A., Inc.
$18
Incyte Corporation
$16
Top 3 companies account for 50.6% of total payments
Associated products mentioned in payments ›
ADCETRIS · BRAC CDx · BRACANALYSIS CDX · BRACAnalysis CDx · ELEKTA MEDICAL LINEAR ACCELERATOR · ELIGARD · ERLEADA · Enhertu · FLEXITOUCH · FRUZAQLA · Flexitouch Plus · GELCLAIR CONCENTRATED ORAL GEL · Halcyon · IMFINZI · JAKAFI · KEYTRUDA · KISQALI · LIBTAYO · MONOFERRIC · MRIdian LINAC · MYRISK · Neuroblate · ORGOVYX · Optune · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PTS250 · Poteligeo · Prolaris · TEPMETKO · TUKYSA · TheraSphere Y90 Glass Microspheres 10 GBq · VERZENIO · Varian Ethos Treatment Planning · XTANDI · Xofigo
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $234 per 100 Medicare services performed
Looking for an optician specialist in Orlando?
Compare opticians in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
336
Per 100K population
23.3
County median income
$77,011
Nearest hospital
ASPIRE HEALTH PARTNERS
3.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Forouzannia is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Forouzannia experienced with stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy?
Based on Medicare claims data, Dr. Forouzannia performed 339 stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Forouzannia receive payments from pharmaceutical companies?
Yes. Dr. Forouzannia received a total of $3,309 from 32 companies across 72 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Forouzannia's costs compare to other opticians in Orlando?
Dr. Forouzannia's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Forouzannia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →